MBiotech Student Projects

MBiotech

MBiotech Student Projects

MBiotech students have the opportunity to work on a number of faculty-mentored projects in courses such as Biotech in Medicine, the MBiotech Seminar Series and Supervised Study courses. Student teams tackle challenges pertient to the biotech, medical device and biopharma industries. These are broad in scope and may include publishable research and/or product focused company solutions. These projects presented to faculty, student peers, industry partners and colleagues at leading teaching hospitals. 

A few examples of the quality of work produced by student teams as part of course work in the MBiotech Program follow. Many of the projects involve entrepreneurial ideas and are associated with products, as yet unapproved, and a second type of project involves intrapreneurial innovations, where student teams re-visit an existing product and consider how to re-task it for purposes of generating a new revenue stream.

 

GE Portable Ultrasound 

Course: Seminar Series (BTC1600H)
Problem: How can reimbursement barriers to portable ultrasound be overcome? 
Solution: "Piggyback" ultrasound use off of reimbursed asymptomatic cardiac patients.
Outcome: General Electric creates first student internship position. Presented to AstraZeneca senior management and at conference.

Picture of mbiotech group for GE Portable Ultrasound

 

iPhone Medical Imaging

Course: Seminar Series (BTC1600H)
Problem: Find a medical application uniquely suited to iPhone medical imaging.
Solution: Stroke (ICH) imaging of "SpotSigns" in patients who need assessment urgently.
Outcome: Radiologists showed strong interest in the project. Project on hold until "SpotSign" phase III done.

Picture of mbiotech group for iPhone Medical Imaging
Team ViaVive - iPhone Medical Imaging

 

Abbott's C. Difficile Screening

Course: Seminar Series (BTC1600H)
Problem: Drive sales for e.coli screening product line in what is a commodity market.
Solution: "Hub Model" of cost sharing centralizing regional testing.
Outcome: Active participation of Abbott's product manager. Strong MBiotech interest, working on first internships.

Ingenia
Team Ingenia - Abbott's C. Difficile Screening

 

Ireland's Crescent Inc.

Course: Supervised Study (BTC2100Y, BTC2110H, BTC2120H)
Problem: A student team worked on a commercialization plan for a new technology being developed by Crescent Diagnostics, a start-up company based in Ireland.
Solution: The student team came up with an early commercialization strategy that would position the technology as a supplemental tool to facilitate off label treatment decisions.
Outcome: The student team presents via webcast to the management team based in Ireland.  So far, the firm has shown considerable interest and the team has worked on closely with physicians in different specializations.

Picture of mbiotech group for Irelands Crescent Inc

 

Calgary Scientific Mobile Imaging

Course: Supervised Study (BTC2110H)
Problem: What kind of study and indication are required to drive product sales?
Solution: In progress - technology may be offered as part of a suite of services to radiologists.
Outcome: In progress. Presentation to company in April.

Picture of mbiotech group for Calgary Scientific Mobile Imaging

 

Internet Medical Records

Course: Biotech in Medicine (BTC1800H)
Problem: Can hospitals collect health outcome data on drugs to industry and government?
Solution: Internet database pilot study in trauma care.
Outcome: Presented to Ministry of Health in 2011 for funding. Provincial wide clinical study funding submission to CIHR involving 10 teaching hospitals, based entirely upon the student work performed for their project in Biotech in Medicine.

Picture of mbiotech group for Internet Medical Records

 

Medical Device Reprocessing

Course: Biotech in Medicine (BTC1800H)
Problem: What kind of study would be of interest to industry and address concerns of hospitals re: device reprocessing?
Solution: Proposed a prospective observational study tracking the safety outcomes of reprocessing a specific medical device that represents high risk in patient care.
Outcome: Stryker negotiations serious but not successful. JNJ now reviewing proposal.

Picture of mbiotech group for Internet Medical Records
Team IDIA Technologies - Medical Device Reprocessing
 

GSK's Benlysta in Brazil

Course: Life Sciences Series (BTC 1600H)
Problem: What market penetration strategy is required for Brazil if this product is approved for sale?
Solution: Subsidized transportation of patients from rural areas who are reimbursable, to urban infusion clinics.
Outcome: GSK South America brand manager attention at presentation and review by epidemiologist.

Team Aithon
Team Aithon - GSK's Benlysta in Brazil

 

Drug Eluting Stents

Course: Supervised Study Projects (BTC2110H)
Challenge: To identify the clinical trial risk contributions of strut design and drug choices in drug eluting stents.
Solution: Analyzed clinical trial failure rates by drug and stent design as two separate variables.
Outcome: Data and conclusions have been compiled. The team is now pursuing a cardiologist to co-author the work and push the work toward a publication.

Mbiotech team for Drug Eluting Stents

 

Medtronic's Insulin Pump

Course: Seminar Series (BTC1600H)
Problem: To drive sales of Medtronic's insulin pump.
Solution: Product modification involving a smartphone for ease of access to glucose readings.
Outcome: Presentation to entire Medtronic senior management team at head office. JNJ now reviewing proposal as they also offer an insulin pump product line.

Team 4Site
Team 4SITE - Medtronic Insulin Pump

 

For more information...

See news item: "MBiotech Tapping into Medical Devices" (November 23, 2011)

See "MBiotech Innovator Awards" (PDF document) outlining the above projects.


FacebookTwitterLinkedIn